SKY Updates Archives - Sky Foundation Inc

Detroit Sports Voice Pat Caputo Passes Away Following Pancreatic Cancer Battle

The Metro Detroit community is mourning the loss of longtime sports journalist and radio personality Pat Caputo, who passed away following a battle with pancreatic cancer. Known for his decades of passionate sports coverage and unmistakable voice across Detroit media, Caputo left a lasting impact on generations of fans throughout Michigan.

As friends, colleagues, and listeners reflect on his legacy, his passing also serves as a reminder of the urgent need for continued awareness, research, and progress in the fight against pancreatic cancer. At Sky Foundation, we extend our heartfelt condolences to Pat Caputo’s family, friends, and all who were touched by his work and presence.

🔗 Read the original article: https://www.detroitnews.com/story/sports/other/2026/05/07/pat-caputo-longtime-metro-detroit-sports-personality-passes-away/89981275007/

Researchers at the Mayo Clinic have developed an artificial intelligence (AI) tool that may be able to detect pancreatic cancer

A recent New York Times report highlights two experimental drugs generating optimism in the treatment of pancreatic cancer, a disease

A groundbreaking early-stage clinical trial is offering new hope in the fight against pancreatic cancer. Researchers have developed a personalized

A promising new treatment for pancreatic cancer is showing encouraging results, with researchers reporting that the drug may nearly double

Johns Hopkins Study Identifies “Master Gene” Driving Pancreatic Cancer Spread

A groundbreaking study from researchers at Johns Hopkins has identified a key “master gene” that plays a powerful role in driving pancreatic cancer metastasis—the process by which cancer spreads to other organs. The research highlights

Recent federal budget decisions signal renewed national momentum for cancer research—including meaningful progress for pancreatic cancer. In March 2026, Congress

A groundbreaking review led by researchers at the Barbara Ann Karmanos Cancer Institute and Wayne State University—including longtime Sky Foundation

No one expects to be told they have pancreatic cancer in the emergency room, with less than a 1% chance

Pancreatic Cancer Awareness Month -- Learn who's at risk

Sky Support Circle

Continuing the Legacy of Compassion The Sky Support Circle was created in the spirit of our founder, Sheila Sky Kasselman, who built Sky Foundation on one simple but powerful belief — that no one facing

Date & Time: Tuesday, November 18, 2025 Location: Online via Microsoft Teams 🎟️ Register Here Understanding Genetic Risk & Early

Dr. Harrison L. Hiraki Harrison L. Hiraki, PhD — Rogel and Blondy Cancer Center (University of Michigan) Dr. Hiraki is advancing our understanding

Sky Foundation created the Shine Like Sheila Award to honor the legacy of founder and pancreatic cancer survivor Sheila Kasselman,

At the Night Sky Gala, an unexpected medical emergency in the audience required us to pause the program. We're

Phase 1/2 Trial Launches for Innovative Pancreatic Cancer Immunotherapy

UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced pancreatic cancer. The study, listed

FDA Approves NALIRIFOX for Metastatic Pancreatic Cancer

New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA)

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like

UCLA’s Dr. Zev Wainberg discusses results from the AMPLIFY-201 trial and hopes for next-generation vaccines. Researchers are exploring new ways

Independent committee recommends ELI-002 7P Phase 2 study continue without changes. Elicio Therapeutics has announced encouraging news for its pancreatic

Off-the-Shelf Cancer Vaccine Shows Strong Results in Pancreatic and Colorectal Cancer Patients

UCLA-led study reports durable immune responses and reduced relapse in patients with KRAS-driven cancers. A groundbreaking study led by UCLA Health researchers has shown promising results for an experimental off-the-shelf cancer vaccine, ELI-002 2P, in

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. With a survival rate of just 13%, finding

Sky Foundation Featured on Fox 2 Detroit We are honored to have been featured on Fox 2 Detroit, highlighting Sky

Sky Foundation is proud to highlight the success of a rising cancer researcher from the lab of Dr. Asfar Azmi

The Sky Foundation Inc. in Birmingham, a 501(c)(3) nonprofit organization that raises awareness for pancreatic cancer and funds scientific research

Key to the High Aggressiveness of Pancreatic Cancer Identified

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor microenvironment, known as

A new study published in Cancer highlights significant racial and socioeconomic disparities in treatment and survival outcomes for patients with

LEGASEA Aquarium and Reptarium officially opens its doors on April 21, bringing to life the vision of the late Brian

Biobank of tumor tissue and advanced molecular profiling steer researchers toward new targeted therapies Other than a fleeting moment in

A major step forward in pancreatic cancer research! Scientists at Oregon Health & Science University (OHSU) have developed a blood

Clinical Validation of Next-Generation Test for Early-Stage Pancreatic Cancer

Immunovia announces positive outcome and strong accuracy in the clinical validation of its next-generation test for pancreatic cancer LUND, Sweden, Dec. 9, 2024 /PRNewswire/ -- Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces the

ANN ARBOR, Michigan — With a $50 million gift from Richard and Susan Rogel, the University of Michigan Health Rogel

President Biden and first lady Jill Biden touts the Biden Cancer Moonshot Initiative, which aims to boost funding research and

Congratulations to our very own Leigh Settemoir Ph.D., MBA, SPHR on receiving Oakland University's Staff Excellence Award in Community

Sky Foundation, Inc. held its 2024 Doctail Mixer event at Pine Lake Country Club in West Bloomfield on July 24th.

Scientists make DNA discovery that could help find pancreatic cancer cure

There is HOPE for new treatments after researchers find spread of disease is aided by shutting down of molecules in key genes. Scientists have made a crucial DNA discovery that could help cure one of

Rep. Sheila Jackson Lee, D-Texas, had announced a short time ago that she has been diagnosed with pancreatic cancer. She

MONDAY, April 8, 2024 (HealthDay News) -- A blood test appears capable of detecting early-stage pancreatic cancers with up to

Kate's, the Princess of Wales, diagnosis of cancer at the young age of 42 years has caught many by surprise,

Wayne State University and Barbara Ann Karmanos Cancer Institute researchers say a new federal grant will help them investigate genetic cancer risks

Latest Cutting-edge Technology & Digital Spatial Profiling at Karmanos Cancer Institute

Selinexor Provides Hope Barbara Ann Karmanos Cancer Institute recently published a study investigating the molecular mechanism of action of Selinexor in pancreatic ductal adenocarcinoma and the tumor’s surrounding microenvironment. Sky's funded researcher, Asfar Azmi, Ph.D.,

An officer in the U.S. Air Force was crowned Miss America on Sunday night. Second Lt. Madison Marsh is the

Pancreatic Cancer 5 year survival rate increases to 13% which means more hope. In terms of lives extended, this one

Very hopeful news! Karmanos Cancer Institute, the largest provider of cancer care and research in Michigan and part of McLaren

HOUR DETROIT HIGHLIGHTS NIGHT SKY GALA Guests at Sky Foundation, Inc.’s Night Sky Gala on Nov. 9, 2023, enjoyed ”an

New mRNA Pancreatic Cancer Vaccine Trial Starts Next Phase After Promising Results

A revolutionary approach to treating pancreatic cancer is progressing to the next step in making it available to more patients. After encouraging results from a small study, a phase 2 clinical trial has now opened

Sky Foundation Announces Successor & New Executive Director July 10, 2023 – Bloomfield Hills, Mich. – Sky Foundation,

A scarcity of cancer drugs has heightened concerns about the troubled generic drug industry. Congress and the White House are